Connection

Sheldon Litwin to Heart Failure

Back to Details
This is a "connection" page, showing publications Sheldon Litwin has written about Heart Failure.
Sheldon Litwin
Connection Strength
4.675
Heart Failure
  1. Pragmatic Weight Management Program for Patients With Obesity and Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2021 11 02; 10(21):e022930.
    View in: PubMed
    Score: 0.421
  2. Pharmacologic Weight Loss for Heart Failure With Preserved Ejection Fraction: Getting to the Core of the Problem. Circ Heart Fail. 2021 09; 14(9):e008554.
    View in: PubMed
    Score: 0.417
  3. The Vexing Problem of HFpEF?Therapeutics: Inching Toward Success. JACC Heart Fail. 2021 05; 9(5):371-373.
    View in: PubMed
    Score: 0.407
  4. Should We Test for Diastolic Dysfunction? How and How Often? JACC Cardiovasc Imaging. 2020 01; 13(1 Pt 2):297-309.
    View in: PubMed
    Score: 0.357
  5. Redefining Reverse Remodeling: Can Echocardiography Refine Our Ability to Assess Response to Heart Failure Treatments? J Am Coll Cardiol. 2016 09 20; 68(12):1277-80.
    View in: PubMed
    Score: 0.295
  6. Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy. J Card Fail. 2012 Nov; 18(11):837-44.
    View in: PubMed
    Score: 0.226
  7. Is there a cardiomyopathy of obesity? Curr Heart Fail Rep. 2007 Dec; 4(4):221-8.
    View in: PubMed
    Score: 0.160
  8. The growing problem of obesity and the heart: the plot "thickens". J Am Coll Cardiol. 2006 Feb 07; 47(3):617-9.
    View in: PubMed
    Score: 0.141
  9. Close coupling of systolic and diastolic function: combined assessment provides superior prediction of exercise capacity. J Card Fail. 2005 Sep; 11(7):516-22.
    View in: PubMed
    Score: 0.137
  10. Dapagliflozin for heart failure according to body mass index: the DELIVER trial. Eur Heart J. 2022 11 01; 43(41):4406-4417.
    View in: PubMed
    Score: 0.113
  11. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort. Eur J Heart Fail. 2022 08; 24(8):1410-1414.
    View in: PubMed
    Score: 0.110
  12. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet. 2022 03 19; 399(10330):1130-1140.
    View in: PubMed
    Score: 0.107
  13. Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction. ESC Heart Fail. 2022 02; 9(1):186-195.
    View in: PubMed
    Score: 0.106
  14. Lessons from SGLT-2 inhibitors: rethinking endpoints for heart failure studies. Nat Med. 2021 11; 27(11):1872-1873.
    View in: PubMed
    Score: 0.105
  15. Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations. Eur J Heart Fail. 2021 07; 23(7):1076-1084.
    View in: PubMed
    Score: 0.102
  16. Prevention of abnormal sarcoplasmic reticulum calcium transport and protein expression in post-infarction heart failure using 3, 5-diiodothyropropionic acid (DITPA). J Mol Cell Cardiol. 2000 Nov; 32(11):1939-53.
    View in: PubMed
    Score: 0.098
  17. Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure. J Am Heart Assoc. 2020 09; 9(17):e016760.
    View in: PubMed
    Score: 0.097
  18. Longitudinal Changes in Cardiac Structure and Function in Severe Obesity: 11-Year Follow-Up in the Utah Obesity Study. J Am Heart Assoc. 2020 06 16; 9(12):e014542.
    View in: PubMed
    Score: 0.095
  19. Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart?Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2019 11 26; 74(21):2539-2550.
    View in: PubMed
    Score: 0.092
  20. Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial). Am J Cardiol. 2019 12 15; 124(12):1912-1917.
    View in: PubMed
    Score: 0.091
  21. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond. Coron Artery Dis. 1999 Sep; 10(6):361-8.
    View in: PubMed
    Score: 0.091
  22. Effects of stimulation frequency on calcium transients in noninfarcted myocardium: modulation by chronic captopril treatment. J Card Fail. 1999 Sep; 5(3):224-35.
    View in: PubMed
    Score: 0.091
  23. Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. Br J Pharmacol. 1999 Aug; 127(7):1671-9.
    View in: PubMed
    Score: 0.090
  24. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail. 2019 May; 25(5):380-400.
    View in: PubMed
    Score: 0.088
  25. Lifestyle Modifications for Preventing?and Treating Heart?Failure. J Am Coll Cardiol. 2018 11 06; 72(19):2391-2405.
    View in: PubMed
    Score: 0.086
  26. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018 10 01; 3(10):968-977.
    View in: PubMed
    Score: 0.085
  27. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018 01 23; 137(4):364-375.
    View in: PubMed
    Score: 0.080
  28. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol. 1993 Oct; 22(4 Suppl A):49A-55A.
    View in: PubMed
    Score: 0.060
  29. Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure. Circ Res. 1992 Oct; 71(4):797-807.
    View in: PubMed
    Score: 0.056
  30. PGC-1? deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res. 2011 Sep 16; 109(7):783-93.
    View in: PubMed
    Score: 0.052
  31. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation? Am J Cardiol. 2010 Dec 01; 106(11):1657-62.
    View in: PubMed
    Score: 0.049
  32. The associations between tricuspid annular plane systolic excursion (TAPSE), ventricular dyssynchrony, and ventricular interaction in heart failure patients. Eur J Echocardiogr. 2008 Nov; 9(6):766-71.
    View in: PubMed
    Score: 0.041
  33. Integrin activation in the heart: a link between electrical and contractile dysfunction? Circ Res. 2006 Dec 08; 99(12):1403-10.
    View in: PubMed
    Score: 0.037
  34. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995 May 15; 91(10):2642-54.
    View in: PubMed
    Score: 0.017
  35. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol. 1995 Jan; 27(1):383-96.
    View in: PubMed
    Score: 0.016
  36. Effects of treppe and calcium on intracellular calcium and function in the failing heart from the spontaneously hypertensive rat. Hypertension. 1994 Sep; 24(3):347-56.
    View in: PubMed
    Score: 0.016
  37. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation. 1994 Jan; 89(1):345-54.
    View in: PubMed
    Score: 0.015
  38. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res. 1993 May; 27(5):731-5.
    View in: PubMed
    Score: 0.015
  39. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest. 1992 Oct; 90(4):1523-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.